Activest Wealth Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20
Closed -$2.35K 919
2024
Q3
$2.58K Hold
20
﹤0.01% 415
2024
Q2
$2.27K Buy
+20
New +$2.14K ﹤0.01% 393
2023
Q2
Sell
-2
Closed -$191 366
2023
Q1
$191 Hold
2
﹤0.01% 307
2022
Q4
$290 Hold
2
﹤0.01% 441
2022
Q3
$0 Hold
2
﹤0.01% 545
2022
Q2
$0 Hold
2
﹤0.01% 385
2022
Q1
$1K Hold
2
﹤0.01% 322
2021
Q4
$1K Hold
2
﹤0.01% 312
2021
Q3
$2K Hold
2
﹤0.01% 329
2021
Q2
$3K Hold
2
﹤0.01% 283
2021
Q1
$3K Buy
+2
New +$4.68K ﹤0.01% 263

Other funds holding LABU

Activest Wealth Management's LABU Position: Q4 2024 in Review

Activest Wealth Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2024, closing a stake of 20 shares — an estimated $2.35K sold.

Activest Wealth Management first reported a position in LABU in Q1 2021 and held it in 11 quarters. The position peaked at $3K in Q2 2021. 37 funds tracked by Wall St. Rank hold LABU as of Q4 2024.

  • Activest Wealth Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2024 after selling out during the quarter.
  • Activest Wealth Management sold 20 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2024, an estimated $2.35K.
  • Activest Wealth Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2021 and held it in 11 quarters.
  • Activest Wealth Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $3K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2024.

Based on Activest Wealth Management's 13F filing for Q4 2024, filed 28 Jan 2025.